Insider · CIK 0001138558

HAFT JAY M

Reports to the SEC for 7 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001138558

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-01-03	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+5,038 sh	—	—	103,714
2019-06-25	KINSKINGSTONE COMPANIES, INC.P Purchase	Director	PPurchase	+2,000 sh	$8.50	+$17K	98,676
2019-05-20	KINSKINGSTONE COMPANIES, INC.P Purchase	Director	PPurchase	+2,000 sh	$9.00	+$18K	96,676
2019-01-02	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+2,253 sh	—	—	94,676
2018-01-16	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+2,000 sh	—	—	92,423
2017-02-14	KINSKINGSTONE COMPANIES, INC.S Sale	Director	SSale	−45.2K sh	$11.31	−$511K	90,423
2017-01-31	KINSKINGSTONE COMPANIES, INC.S Sale	Director	SSale	−38.6K sh	$11.31	−$437K	135,641
2017-01-04	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+2,000 sh	—	—	174,275
2016-01-04	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+2,000 sh	—	—	172,275
2015-11-30	Neurotrope, Inc.C Conversion	Director	CConversion	+88.3K sh	$0.84	+$74K	88,252
2015-11-30	Neurotrope, Inc.Series A Convertible Preferred StockC Conversion	Director	CConversion	−74K sh	—	—	0
2015-11-19	Neurotrope, Inc.Options (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2015-11-13	Neurotrope, Inc.Series C WarrantP Purchase	Director	PPurchase	+41.7K sh	—	—	41,667
2015-11-13	Neurotrope, Inc.Series A WarrantP Purchase	Director	PPurchase	+41.7K sh	—	—	41,667
2015-11-13	Neurotrope, Inc.Series E WarrantP Purchase	Director	PPurchase	+41.7K sh	—	—	41,667
2015-11-13	Neurotrope, Inc.Series D WarrantP Purchase	Director	PPurchase	+41.7K sh	—	—	41,667
2015-11-13	Neurotrope, Inc.Series B Preferred StockP Purchase	Director	PPurchase	+416.67 sh	—	—	41,667
2015-11-13	Neurotrope, Inc.Series B WarrantP Purchase	Director	PPurchase	+41.7K sh	—	—	41,667
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCU Disposition from Tender	Director	UDisposition from Tender	−50.3K sh	$8.00	−$402K	0
2012-12-20	DUSA PHARMACEUTICALS INCU Disposition from Tender	Director	UDisposition from Tender	−34.5K sh	$8.00	−$276K	0
2012-12-20	DUSA PHARMACEUTICALS INCU Disposition from Tender	Director	UDisposition from Tender	−13.8K sh	$8.00	−$110K	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2012-12-20	DUSA PHARMACEUTICALS INCNon-qualified Stock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2012-06-30	DUSA PHARMACEUTICALS INCA Award	Director	AAward	+8,000 sh	—	—	64,000
2012-03-13	DUSA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$2.90	+$29K	56,000
2012-03-13	DUSA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$2.51	+$25.1K	46,000
2012-03-13	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2012-03-13	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2011-08-09	DUSA PHARMACEUTICALS INCP Purchase	Director	PPurchase	+1,500 sh	$4.10	+$6,150	36,000
2011-08-09	DUSA PHARMACEUTICALS INCP Purchase	Director	PPurchase	+1,500 sh	$4.00	+$6,000	34,500
2011-06-30	DUSA PHARMACEUTICALS INCA Award	Director	AAward	+8,000 sh	—	—	33,000
2010-09-30	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+1,147 sh	—	—	168,621
2010-06-30	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+962 sh	—	—	167,474
2010-06-30	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2010-05-06	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+756 sh	—	—	166,512
2010-03-05	DUSA PHARMACEUTICALS INCP Purchase	Director	PPurchase	+10K sh	$1.72	+$17.2K	25,000
2009-12-31	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+1,674 sh	—	—	165,756
2009-07-28	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+1,361 sh	—	—	164,082
2009-06-30	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2009-03-13	DUSA PHARMACEUTICALS INCA Award	Director	AAward	+15K sh	—	—	15,000
2008-06-30	KINSKINGSTONE COMPANIES, INC.A Award	Director	AAward	+2,475 sh	—	—	159,596
2007-06-30	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2006-07-06	MOSCOW CABLECOM CORPA Award	Director	AAward	+1,250 sh	—	—	24,588
2006-06-30	DUSA PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2006-01-03	MOSCOW CABLECOM CORPA Award	Director	AAward	+5,000 sh	—	—	10,000

Recent filings

Accepted (ET)
Jan 74
HAFT JAY M0001567619-20-000716
SEC(opens sec.gov)
Jun 274
HAFT JAY M0001654954-19-007738
SEC(opens sec.gov)
May 224
HAFT JAY M0001654954-19-006473
SEC(opens sec.gov)
Jan 44
HAFT JAY M0001654954-19-000135
SEC(opens sec.gov)
Jan 174
HAFT JAY M0001140361-18-002102
SEC(opens sec.gov)
Feb 154
KINGSTONE COMPANIES, INC.0001140361-17-007711
SEC(opens sec.gov)
Feb 14
KINGSTONE COMPANIES, INC.0001140361-17-003873
SEC(opens sec.gov)
Jan 64
KINGSTONE COMPANIES, INC.0001140361-17-000920
SEC(opens sec.gov)
Jan 54
KINGSTONE COMPANIES, INC.0001140361-16-046465
SEC(opens sec.gov)
Dec 154
Neurotrope, Inc.0001144204-15-071030
SEC(opens sec.gov)
Nov 204
Neurotrope, Inc.0001144204-15-067341
SEC(opens sec.gov)
Nov 174
Neurotrope, Inc.0001144204-15-066386
SEC(opens sec.gov)
Dec 204
HAFT JAY M0001209191-12-058859
SEC(opens sec.gov)

Companies

Address

110 EAST 57TH STREET SUITE 14A

NEW YORK, NY, 10022